Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study

BACKGROUND: Aspirin has been proposed as a novel adjuvant agent in colorectal cancer (CRC). Six observational studies have reported CRC-specific survival outcomes in patients using aspirin after CRC diagnosis but the results from these studies have been conflicting. Using a population-based cohort d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Ronan T., Coleman, Helen G., Hughes, Carmel, Murray, Liam J., Cardwell, Chris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389196/
https://www.ncbi.nlm.nih.gov/pubmed/29486728
http://dx.doi.org/10.1186/s12885-018-4142-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389196/
https://www.ncbi.nlm.nih.gov/pubmed/29486728
http://dx.doi.org/10.1186/s12885-018-4142-y

Ejemplares similares